InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
8
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Cassella James V, Directeur du Développement. Insider active across 1 company, notably Concert Pharmaceuticals, INC.. Aggregated, 11 reports have been published. Split: 0 buy · 8 sells. Total volume traded: €198k. History available since 16 August 2021. The latest transaction was disclosed on 15 February 2023 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations11 total
80,595 sharesCommon StockSEC:0001209191-23-016163:0
3,762 shares@ US$8.3414.7% of flowCommon StockSEC:0001209191-23-009949:0
10,106 shares@ US$8.3539.1% of flowCommon StockSEC:0001209191-23-005620:0
2,893 shares@ US$7.2510.0% of flowCommon StockSEC:0001209191-23-002551:0
3,762 shares@ US$3.0914.3% of flowCommon StockSEC:0001209191-22-010072:0
75,800 sharesCommon StockSEC:0001209191-22-005876:0
75,800 sharesCommon StockSEC:0001209191-22-005876
2,894 shares@ US$3.194.1% of flowCommon StockSEC:0001209191-22-002401
2,894 shares@ US$3.1911.4% of flowCommon StockSEC:0001209191-22-002401:0
8,086 shares@ US$3.2831.4% of flowCommon StockSEC:0001209191-21-051819:0
8,086 shares@ US$3.2811.3% of flowCommon StockSEC:0001209191-21-051819
11 of 11 declarations
About Cassella James V
James V. Cassella is the Chief Development Officer of CONCERT PHARMACEUTICALS, INC. He oversees product development and research initiatives. James plays a key role in the innovation and growth strategy of the company.
